Inspire Medical Systems Inc. Inspire Model 3028, IV Implantable Pulse Generator Recall
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Inspire Model 3028, IV Implantable Pulse Generator
Brand
Inspire Medical Systems Inc.
Lot Codes / Batch Numbers
US: UDI/DI 0855728005915, Serial Numbers: AIR324492C, AIR324500C, AIR324506C, AIR324510C, AIR324518C, AIR324523C, AIR324493C, AIR324502C, AIR324507C, AIR324511C, AIR324520C AIR324494C, AIR324503C, AIR324508C, AIR324515C, AIR324521C, AIR324496C, AIR324504C, AIR324509C, AIR324517C, AIR324522C, Europe: UDI/DI 10855728005847, Serial Numbers: AIR324497C, AIR324499C, AIR324505C
Products Sold
US: UDI/DI 0855728005915, Serial Numbers: AIR324492C, AIR324500C, AIR324506C, AIR324510C, AIR324518C, AIR324523C, AIR324493C, AIR324502C, AIR324507C, AIR324511C, AIR324520C AIR324494C, AIR324503C, AIR324508C, AIR324515C, AIR324521C, AIR324496C, AIR324504C, AIR324509C, AIR324517C, AIR324522C; Europe: UDI/DI 10855728005847, Serial Numbers: AIR324497C, AIR324499C, AIR324505C
Inspire Medical Systems Inc. is recalling Inspire Model 3028, IV Implantable Pulse Generator due to There is a potential manufacturing defect which can lead to electrical leakage in the sensing circuit which causes a system malfunction and requires a. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
There is a potential manufacturing defect which can lead to electrical leakage in the sensing circuit which causes a system malfunction and requires a revision surgery to replace the IPG,
Recommended Action
Per FDA guidance
Inspire Medical systems issued an URGENT Medical Device Correction notice to the affected healthcare providers on 05/16/2024 via FedEx overnight. The notice explains the potential problem with the device and risk to the patient and recommends the following actions: We recommend the following actions: " Notify affected patients of this voluntary recall. " Schedule your patient for a monitoring visit to confirm their Inspire therapy is working as intended through waveform and impedance analysis. Monitor patients for reports of variation in stimulation, a lack of therapy effectiveness, or an inability to turn on therapy. " Continue with routine monitoring and conduct waveform and impedance analysis at every routine office visit, as IPG issue may be non-invasively identified with basic waveform and impedance testing. " If abnormal waveforms or impedances are observed, record impedance values at 1.5V, 2.0V, 2.5V, 3.0V and 3.5V. o Let the patient know they will feel 3 short pulses of stimulation. o Some of these stimulation pulses may feel strong. This is normal. " Contact your Inspire representative for additional diagnostic testing and troubleshooting recommendations. For additional questions: please contact your Inspire representative or the Inspire Quality team at ProductRecalls@inspiresleep.com.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026